MENU

Beyer Research

beyer research.PNG
beyer research.PNG

Beyer Research

Call Us: 269-372-7800

Website: http://beyerresearch.com/

Like us on Facebook: Click Here

7110 Stadium Drive Kalamazoo, MI 49009


On Going Clinical Trials at Beyer Research

On Going Clinical Trials - See if you qualify. (Great Information but can take a minute or so to load. You will see "Adobe Connect" after you click)

ON GOING CLINICAL TRIALS CLICK HERE (Great Information but can take a minute or so to load. You will see "Adobe Connect" after you click)

Qualified Volunteers will be compensated for their time and travel.

Beyer Research is always looking for Male and Female volunteers for clinical trials for conditions including:

  • Sexual Medicine
  • Hypertension
  • Overactive Bladder
  • IBS
  • Headaches
  • Women's Health Studies


A Message from Dr. Beyer

I swore an oath many years ago. In taking that oath, I said: 'I will prescribe regimens for the good of my patients according to my ability and my judgment and never do harm to anyone.'

I have always felt that it is my duty as a physician to engage in the clinical research and drug development process in order to keep true to my word. Without clinical research, the standard of care will plateau and then decline. If that were to happen, it would mean a decline in advancements in healthcare and medicine that could help all of us.

Research is my passion. I am proud to dedicate the time that it takes to bring advancements to the public. In addition to providing the possibility of better care to my patients, I feel very grateful knowing that, when I look at my children and grandchildren, I am doing all I can to secure a brighter, healthier future for them.

I am more grateful, however, to the countless number of selfless men and women who have chosen to give all of us the greatest gift, the decision to participate in clinical trials.

Sincerely,

Dr. Roger Beyer


Why I Don't "Want" My Husband Anymore!

There are currently no FDA-approved treatments for low libido in women.

Imagine being diagnosed with a disease that plagues millions of other people and then finding out that there are no FDA-approved drugs to treat it. For women with low libido, this is the unfortunate and long-ignored reality. But there's hope on the horizon: The FDA held a two-day landmark meeting to address female sexual dysfunction in October 2014, inviting sufferers to share their struggles and, if they've found relief, what worked for them.

This is a really important time, because the FDA is realizing that women deserve the same sexual rights as men. This is the first time that they've really gone after patient perspective. They didn't want to hear from the researchers or doctors they wanted to hear from women suffering from the problem.

In the last year, female sexual dysfunction has received increasing attention as a grossly under-diagnosed and under-treated issue. On Jan. 27, four congresswomen sent a letter to the FDA, pointing out the embarrassing disparity between sexual-dysfunction treatment options for men and women. On Oct. 23, a group of 83 medical professionals urged the FDA to make female sexual dysfunction a priority. Even the Score, a campaign for sexual-health equality, has started a petition to push the problem to the forefront of the FDA's proceedings.

View the full recorded meeting here

View live testimonials of real women from the meeting by starting Presentation

Despite this lack of attention, the problem is vast: By some estimates, nearly half 43 percent of women in the U.S. suffer from sexual dysfunction, with the most common diagnosis being hypoactive sexual desire disorder (HSDD), or low libido. Leaving this condition untreated while addressing men's sexual difficulties is a recipe for dissatisfaction. According to Dr. Beyer and other physicians "By improving a man's sex drive and ability to get an erection but not increasing his partner's libido, you're creating problems. It's almost a setup for conflict." In fact, in a 2011 study in the Archives of Sexual Behavior, men who reported higher desire than their significant other tended to feel dissatisfied in their long-term relationships.

And when a woman is disturbed by her sexual difficulties, the effects can be far-reaching. As Michelle King Robson, founder of EmpowHER and a former sexual-dysfunction sufferer, said at the meeting held by FDA, "[Sexual dysfunction] ruins the quality of women's lives. It impacts our ability to be productive contributors to the U.S. economy. It harms men and families when it destroys relationships and marriages."

Although there is a drug available in Europe to treat HSDD, the FDA rejected this testosterone-based treatment due to safety concerns. The result: The U.S. is lagging behind. In Europe, they take this condition very seriously. There have been numerous studies looking at this issue most of them have been out of the U.S. in Australia and Europe.

We need more therapies. We have to have something on-label for women. The FDA's public workshop represents a historic moment in the fight for gender equity in sexual health. We hope that the outcome of this process is approval by the FDA of safe and effective treatments for women's most common sexual complaint.


Beyer Research

Call Us: 269-372-7800

Website: http://beyerresearch.com/

Like us on Facebook: Click Here

7110 Stadium Drive Kalamazoo, MI 49009

FOLLOW US ON TWITTER